Cargando…
Desirable Characteristics of Hepatitis C Treatment Regimens: A Review of What We Have and What We Need
There have been dramatic advancements in the treatment of chronic hepatitis C (HCV) infection. This is largely due to the approval of several direct-acting antiviral agents (DAAs) from a variety of medication classes with novel mechanisms of action. These therapies are a welcomed advancement given t...
Autores principales: | Bidell, Monique R., McLaughlin, Milena, Faragon, John, Morse, Caroline, Patel, Nimish |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5019974/ https://www.ncbi.nlm.nih.gov/pubmed/27384319 http://dx.doi.org/10.1007/s40121-016-0118-x |
Ejemplares similares
-
Population Equation: Balancing What We Need With What We Have
por: Dahl, Richard
Publicado: (2005) -
Drugs for malaria elimination: what do we have now and what do we need?
por: Shanks, Dennis
Publicado: (2014) -
Neurophysiology of the Developing Cerebral Cortex: What We Have Learned and What We Need to Know
por: Luhmann, Heiko J.
Publicado: (2022) -
Diagnostic Bioliquid Markers for Pancreatic Cancer: What We Have vs. What We Need
por: Liou, Geou-Yarh, et al.
Publicado: (2023) -
Animal Models for Fibrotic Liver Diseases: What We Have, What We Need, and What Is under Development
por: Delire, Bénédicte, et al.
Publicado: (2015)